Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terry Treadwell

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Advances in Skin & Wound Care|October 20, 2017
Oxidized Regenerated Cellulose/Collagen Dressings: Review of Evidence and RecommendationsStephanie Wu, Andrew J Applewhite, Jeffrey Niezgoda, et al.
Journal of Wound Care|September 17, 2024
Efficacy and safety of autologous whole blood clot in diabetic foot ulcers: a randomised controlled trialRobert Snyder, Aksone Nouvong, Jesus Ulloa, et al.
Lancet (London, England)|March 16, 2020
Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trialRichard O Phillips, Jérôme Robert, Kabiru Mohamed Abass, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Advances in Skin & Wound Care|October 20, 2017
Oxidized Regenerated Cellulose/Collagen Dressings: Review of Evidence and RecommendationsStephanie Wu, Andrew J Applewhite, Jeffrey Niezgoda, et al.
Journal of Wound Care|September 17, 2024
Efficacy and safety of autologous whole blood clot in diabetic foot ulcers: a randomised controlled trialRobert Snyder, Aksone Nouvong, Jesus Ulloa, et al.
Lancet (London, England)|March 16, 2020
Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trialRichard O Phillips, Jérôme Robert, Kabiru Mohamed Abass, et al.
Pageof 5